CSCann Social Tonic Financial Model
Health-tech Startup Financials (Free Excel Download)
Cann is a cannabis-infused "social tonic" positioned as a low-dose (2mg THC), health-conscious alternative to alcohol for mainstream/casual consumers.
professionals from Deloitte
Used by professionals from






About this model
Cann is a cannabis-infused social tonic positioned as a low-dose, health-conscious alternative to alcohol. Its product is sold through regulated California dispensaries and built through digitally native brand and community marketing.
The company has confirmed three flavours and relies on micro-influencers, celebrity support, and experiential events to build mainstream awareness. Regulated distribution makes retail availability and compliant supply key operating constraints.
The model should forecast cases and units sold by SKU, wholesale price, dispensary coverage, COGS, and gross margin. Marketing, trade spend, production, inventory, and state-specific regulatory costs should be modelled explicitly.
A turnkey financial model
Live formulas, no hardcoded values
Outputs are driven by live formulas, so the workbook updates from its assumptions instead of relying on hardcoded results.
All assumptions in one tab
Inputs are clearly marked in the Assumptions tab and separated from calculations, making it clear what to change and what to leave intact.
Statements always balancing
For integrated-statement models, the balance sheet, cash flow, and supporting schedules tie through properly.
Distinct schedules for clarity
Debt, working capital, taxes, and cash flow can get messy quickly. We group calculations in clear schedules, not across disconnected tabs.
No hidden macros or external links
There are no unexplained external workbook links or macros to undermine auditability or portability.
Changes flow through the model
Update a key driver and see the impact carry through the forecast, financing, and return outputs. We never use hardcoded numbers in formulas.
About Cann Social Tonic

How to build a detailed financial model for Cann Social Tonic
A complete walkthrough of the business, drivers, and assumptions behind the downloadable Cann Social Tonic model - distilled from its pitch deck and publicly available information.
Product & value proposition
- Product: Cann Social Tonic - a canned, cannabis-infused sparkling beverage.
- Dose: 2mg THC per can - the lowest in the beverage category vs. competitors at 5–100mg.
- Calories: 30 cals per can vs. 100–150 cals for comparable social drinks (gin & tonic ~100, White Claw ~110, Bud Light ~110, Magners ~150).
- Flavors: Blood Orange Cardamom, Grapefruit Rosemary, Lemon Lavender.
- Attributes: Non-GMO, no stevia, no artificial flavors, no gluten.
- Onset: Quick sublingual absorption - uses heuristics from alcohol (drink more than one, gradual controllable build).
- Target consumer: "Canna-Casual" and "Canna-Curious" segments - mainstream adults who currently use alcohol but are seeking healthier social alternatives.
Market
- Low-dose cannabis (≤5mg) is the fastest-growing sub-segment: 2–3x growth vs. all cannabis products.
- Low-dose Colorado growth reached 83% by end of 2017 (source: RBC Capital Markets Equity Research, August 2018).
- 33% of today's cannabis market is low-dose; projected to be 70%+ by 2023 if growth trends continue.
- Addressable behaviour pool: 21 of 25 adult drinkers are trying to reduce or moderate alcohol consumption (source: Beverage Daily).
Revenue model
- Channel: Licensed cannabis retail dispensaries in California (regulated channel); digital/DTC social presence.
- SKU count: 3 flavors confirmed.
- Go-to-market: Digitally native brand - micro-influencer network → mainstream celebrity endorsements. Pop-up/experiential events.
Traction & metrics
- Instagram followers: 1,511 followers, 492 posts at time of deck.
Competition / moat
Direct cannabis beverage competitors (shown in slide 8):
- Lagunitas Hi-Fi Hops: 5–10mg THC
- Hop & Cola, California Dreamin', Sprig, Legal: 10–20mg THC
- Cannabis Quencher, Dixie: 25–100mg THC
- Cann: 2mg THC (lowest dose - clear white space)
Indirect competitors (alcohol substitutes, slide 7):
- Gin & tonic (~100 cals), White Claw (~110 cals), Bud Light (~110 cals), Magners (~150 cals)
- Cann at 30 cals is positioned as materially healthier
Moat claims:
- Lowest dose in segment creates a distinct product category (approachable for non-users)
- Sublingual fast-onset format (not edible) differentiates from slow/unpredictable gummies
- Premium brand aesthetics targeting wellness-oriented mainstream consumer vs. "stoner" imagery
- First-mover in mainstream cannabis social beverage positioning
Notable competitors cited as validation:
- Kiva Confections (Terra Blueberries, 5mg, #1 edible 2017 ERRL Cup)
- Dosist (2.25mg/dose, Fast Company World's 50 most innovative companies 2018)
Team & funding ask / use of funds
Founders:
- Jake Bullock (co-founder): PE, management consulting, IB background; cannabis venture investments; co-President Cannabis Business Club at Stanford GSB; worked at Besito (premium LA cannabis brand). Duke undergrad, Bain Capital, Stanford GSB.
- Luke Anderson (co-founder): 6 years Bain & Company (consumer experience design, product marketing for large CPG); Architecture background; Teach For America; Harvard Business School.
Recommended financial model
- Archetype + why: DTC/CPG Revenue & Gross Margin P&L model, with a volume-based unit economics layer. Cann is a physical product brand in a regulated channel - the model needs to track cases/units sold, revenue per case (wholesale + DTC blended), COGS (production, co-packing, cannabis input), gross margin, and operating expenses (marketing, events, G&A). Not a SaaS or marketplace - no recurring subscription or platform take-rate. Closest analogue: consumer beverage startup P&L (e.g., Liquid Death, Olipop early-stage).
- Forecast horizon & granularity: Monthly for Year 1–2 (pre-profitability, cash-sensitive), quarterly for Years 3–5. 5-year total horizon.
- Key drivers & assumptions:
| Driver | Value |
|---|---|
| Launch state | California |
| SKUs at launch | 3 flavors |
| THC dose per can | 2mg |
| Calories per can | 30 |
| Retail price per can (MSRP) | ~$6–8 |
| Wholesale price per can | ~$3.50–4.50 |
| Case size (cans/case) | 24 |
| Production COGS per can | ~$1.50–2.00 |
| Gross margin (wholesale channel) | ~45–55% |
| Retail door count Year 1 | 25–75 CA dispensaries |
| Cases per door per month | 2–5 |
| DTC / event revenue share | 10–15% of total |
| S&M spend (% revenue) | 30–40% Year 1, declining to 15–20% by Year 3 |
| G&A | $200K–$400K/yr Year 1 |
| Geographic expansion (NM) | Year 2 |
| Low-dose market CAGR | ~2–3x vs. total cannabis (i.e., ~40–60% annual) |
- Scenarios (Base / Bull / Bear - which variables flex):
- Base: 50 retail doors by end of Year 1, 3 cases/door/month, 3 flavors, CA only; NM added Year 2
- Bull: Faster door growth (150+ by Year 1 end), celebrity endorsement accelerates brand velocity, expanded to 3+ states by Year 2
- Bear: Slow dispensary adoption, regulatory friction slows expansion, low-dose segment doesn't achieve projected 70% market share; company stays CA-only through Year 2
- Required sheets / outputs:
- Assumptions - all unit economics, pricing, and door-count inputs
- Revenue build - doors × velocity × price, by channel (wholesale vs. event/DTC) and SKU
- COGS & gross margin - production cost per unit, contribution margin per can/case
- Operating expenses - S&M (influencer, events, billboard), G&A, headcount
- P&L (Income Statement) - monthly Year 1–2, quarterly Year 3–5
- Cash flow & runway - burn rate, implied funding need (no raise stated in deck)
- Market penetration - CA dispensary door count vs. total addressable doors
- Sensitivity table - retail doors × cases/door/month → revenue and gross profit
Frequently asked
Is the Cann Social Tonic financial model free?+
Yes. The Cann Social Tonic model is a free Excel (.xlsx) download with live formulas. Sign up with your email and the workbook is yours to keep, review, and edit.
What's included in the model?+
A 5-year monthly forecast with P&L, cash flow and runway, valuation (exit multiple plus a DCF cross-check), MOIC/IRR returns, and unit economics, with live formulas throughout.
How was this model built?+
It was built from Cann Social Tonic's pitch deck and publicly available information, then structured to investment-banking standards as a fully editable Excel model.
Can I change the assumptions?+
Yes. You can change assumptions and the live formulas will recalculate in the downloadable Excel model.
Have more financial modelling questions? Contact us
Created by ex-finance professionals
Hey, I’m Alex and I created Finamodel.
Over my years in the finance industry I kept building the same models over and over again. Same structure, same assumptions, different logo. So I started building frameworks to turn them into clean, reusable templates.
Every model here is one I’d actually use for a client, and I personally vet each one before it goes up.
I’m not an expert in every industry, but I’ve built enough models to know what belongs in one. And when something is completely foreign to me, I reach out to my network for experts to work on our models with us.
Having a template library on hand cuts a first build from hours to minutes.
Need help finding your model? You’ll find me in the Finamodel app!
Other Health-tech Startup Financial Models
Browse another startup in the same category.
98point6
B2B SaaS platform licensing an AI-powered virtual care technology stack to health systems, pivoted from running a direct-to-employer virtual clinic.
A-Champs
IoT-powered gamified training device (ROXs PRO) for sports/health professionals, evolving into a B2C smart coach app for families.

AccuRx
Patient-centred communication platform connecting everyone involved in a patient's care, starting with near-universal penetration in UK GP practices.

Aeris
Swiss-made premium air purifiers sold through DTC, retail, and dealer channels, with a recurring filter consumable attached to a connected mobile app.

Akido Labs
Akido Labs is a data-driven prevention platform that integrates siloed healthcare, municipal, and non-profit data to enable proactive outreach and case management for vulnerable populations (homeless, chronically ill, etc.).

Alloy
Telehealth + DTC subscription platform delivering menopause hormonal treatment (MHT) and holistic care to U.S. women 40+.

Astek Diagnostics
Point-of-care diagnostic device (Jiddu system) that confirms bacterial infections and antibiotic sensitivity in ~1 hour across four body fluid types (urine, CSF, effluent, blood).

Atom Limbs
Atom Limbs is building the first AI-powered, neural-controlled prosthetic arm sold direct-to-consumer on a subscription model.

